» Authors » Aditya S Shah

Aditya S Shah

Explore the profile of Aditya S Shah including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 79
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
McHugh J, Gomez E, Abu-Saleh O, Corsini Campioli C, Chesdachai S, Nazli S, et al.
Mayo Clin Proc . 2025 Mar; 100(3):534-539. PMID: 40044363
We report a case of mpox in a patient with a signal transducer and activator of transcription 1 gain-of-function mutation. Despite initial improvement with intravenous immune globulin and tecovirimat, severe...
2.
McHugh J, Bayless D, Ranganath N, Stevens R, Kind D, Wengenack N, et al.
J Clin Microbiol . 2024 Oct; 62(11):e0105724. PMID: 39440933
Importance: Our study addresses a significant knowledge gap in the clinical management of this non- species. Our retrospective review includes comprehensive AST data for 112 isolates, which is the largest...
3.
Tabaja H, Chesdachai S, Shah A, Stevens R, DeMartino R, Erben Y, et al.
Clin Infect Dis . 2024 Apr; 78(6):e69-e80. PMID: 38656065
Vascular graft infection (VGI) is one of the most serious complications following arterial reconstructive surgery. VGI has received increasing attention over the past decade, but many questions remain regarding its...
4.
Tabaja H, Chesdachai S, Shah A, Stevens R, DeMartino R, Erben Y, et al.
Clin Infect Dis . 2024 Apr; 78(6):1391-1392. PMID: 38635420
Vascular graft infection (VGI) is one of the most serious complications following arterial reconstructive surgery. VGI has received increasing attention over the past decade, but many questions remain regarding its...
5.
Kasten M, Lahr B, Parisapogu A, Yetmar Z, OHoro J, Orenstein R, et al.
Sci Rep . 2023 Dec; 13(1):21249. PMID: 38040756
The role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent plasma in the treatment of Coronavirus Disease 2019 (COVID-19) in immunosuppressed individuals remains controversial. We describe the course of...
6.
Ranganath N, Yetmar Z, Abu Saleh O, Tande A, Shah A
Transpl Infect Dis . 2023 Nov; 26(1):e14203. PMID: 38010744
Introduction: Gram-negative bacillary bloodstream infection (GN-BSI) is a frequent clinical challenge among immunocompromised hosts and is associated with a high mortality. The utility of follow-up blood cultures (FUBCs) for GN-BSI...
7.
Williamson K, Yun M, Koster M, Arment C, Patnaik A, Chang T, et al.
Rheumatology (Oxford) . 2023 Jul; 63(5):1291-1296. PMID: 37467078
Objectives: Whipple's disease (WD) results from infection of the bacteria Tropheryma whipplei (TW). This disease is characterized by macrophage infiltration of intestinal mucosa and primarily affects Caucasian males. Genetic studies...
8.
Chesdachai S, Yetmar Z, Mendoza M, Ranganath N, Schettle S, Boilson B, et al.
ASAIO J . 2023 Jun; 69(10):950-955. PMID: 37367716
The literature regarding Clostridioides difficile infection (CDI) in left ventricular assist devices (LVADs) patients is limited. Therefore, we aimed to characterize the clinical course, risk factors, management, and outcomes of...
9.
Ranganath N, Yetmar Z, McCandless A, Rivera C, Lahr B, Tande A, et al.
Transpl Infect Dis . 2023 Jun; 25(5):e14085. PMID: 37279240
Background: In the management of Gram-negative bloodstream infection (GN-BSI), short antimicrobial courses have been increasingly demonstrated to be non-inferior to prolonged therapy, with lower risk of Clostridioides difficile infection (CDI)...
10.
Maredia H, Sartori-Valinotti J, Ranganath N, Tosh P, OHoro J, Shah A
Mayo Clin Proc . 2023 May; 98(6):828-832. PMID: 37125977
No abstract available.